{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:12:29Z","timestamp":1783098749022,"version":"3.54.6"},"reference-count":36,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,4]]},"DOI":"10.36660\/abc.20210486","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:55:56Z","timestamp":1652799356000},"source":"Crossref","is-referenced-by-count":2,"title":["Papel Diagn\u00f3stico do NT-proBNP em Pacientes com Comprometimento por Amiloidose Card\u00edaca: Uma Metan\u00e1lise"],"prefix":"10.36660","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-6065","authenticated-orcid":false,"given":"Yingwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-7633","authenticated-orcid":false,"given":"Hasi","family":"Chaolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","reference":[{"issue":"6","key":"key20220517104335_B1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The Amyloid State of Proteins in Human Diseases","volume":"148","author":"Eisenberg","year":"2012","unstructured":"1. Eisenberg D, Jucker M. The Amyloid State of Proteins in Human Diseases. Cell. 2012;148(6):1188-203. doi: 10.1016\/j.cell.2012.02.022.","journal-title":"Cell"},{"key":"key20220517104335_B2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10286-019-00629-5","article-title":"Diagnosis and Treatment of Heart Failure in Hereditary Transthyretin Amyloidosis","volume":"29","author":"Puig-Carrion","year":"2019","unstructured":"2. Puig-Carrion GD, Reyentovich A, Katz SD. Diagnosis and Treatment of Heart Failure in Hereditary Transthyretin Amyloidosis. Clin Auton Res. 2019;29(Suppl 1):45-53. doi: 10.1007\/s10286-019-00629-5.","journal-title":"Clin Auton Res"},{"key":"key20220517104335_B3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable","volume":"71","author":"Rubin","year":"2020","unstructured":"3. Rubin J, Maurer MS. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annu Rev Med. 2020;71:203-19. doi: 10.1146\/annurev-med-052918-020140.","journal-title":"Annu Rev Med"},{"issue":"21","key":"key20220517104335_B4","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week","volume":"74","author":"Ternacle","year":"2019","unstructured":"4. Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, et al. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(21):2638-51. doi: 10.1016\/j.jacc.2019.09.056.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220517104335_B5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art Radionuclide Imaging in Cardiac Transthyretin Amyloidosis","volume":"26","author":"Singh","year":"2019","unstructured":"5. Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S. State-of-the-art Radionuclide Imaging in Cardiac Transthyretin Amyloidosis. J Nucl Cardiol. 2019;26(1):158-73. doi: 10.1007\/s12350-018-01552-4.","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"key20220517104335_B6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin Cardiac Amyloidosis: An Update on Diagnosis and Treatment","volume":"6","author":"Yamamoto","year":"2019","unstructured":"6. Yamamoto H, Yokochi T. Transthyretin Cardiac Amyloidosis: An Update on Diagnosis and Treatment. ESC Heart Fail. 2019;6(6):1128-39. doi: 10.1002\/ehf2.12518.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"key20220517104335_B7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cpcardiol.2017.04.003","article-title":"Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions","volume":"43","author":"Bhogal","year":"2018","unstructured":"7. Bhogal S, Ladia V, Sitwala P, Cook E, Bajaj K, Ramu V, et al. Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions. Curr Probl Cardiol. 2018;43(1):10-34. doi: 10.1016\/j.cpcardiol.2017.04.003.","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"key20220517104335_B8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2016.191","article-title":"Rationale, Application and Clinical Qualification for NT-proBNP as a Surrogate End Point in Pivotal Clinical Trials in Patients with AL Amyloidosis","volume":"30","author":"Merlini","year":"2016","unstructured":"8. Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, et al. Rationale, Application and Clinical Qualification for NT-proBNP as a Surrogate End Point in Pivotal Clinical Trials in Patients with AL Amyloidosis. Leukemia. 2016;30(10):1979-86. doi: 10.1038\/leu.2016.191.","journal-title":"Leukemia"},{"issue":"4","key":"key20220517104335_B9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10741-014-9440-0","article-title":"A Systematic Review of BNP and NT-proBNP in the Management of Heart Failure: Overview and Methods","volume":"19","author":"Oremus","year":"2014","unstructured":"9. Oremus M, McKelvie R, Don-Wauchope A, Santaguida PL, Ali U, Balion C, et al. A Systematic Review of BNP and NT-proBNP in the Management of Heart Failure: Overview and Methods. Heart Fail Rev. 2014;19(4):413-9. doi: 10.1007\/s10741-014-9440-0.","journal-title":"Heart Fail Rev"},{"key":"key20220517104335_B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00059-019-04871-5","article-title":"Cardiac Amyloidosis: In Search of the Ideal Diagnostic Tool","volume":"46","author":"Mavrogeni","year":"2021","unstructured":"10. Mavrogeni SI, Vartela V, Ntalianis A, Vretou R, Ikonomidis I, Tselegkidou M, et al. Cardiac Amyloidosis: In Search of the Ideal Diagnostic Tool. Herz. 2021;46(Suppl 1):9-14. doi: 10.1007\/s00059-019-04871-5.","journal-title":"Herz"},{"issue":"18","key":"key20220517104335_B11","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2010-05-286567","article-title":"The Combination of High-sensitivity Cardiac Troponin T (hs-cTnT) at Presentation and Changes in N-Terminal Natriuretic Peptide Type B (NT-proBNP) After Chemotherapy Best Predicts Survival in AL Amyloidosis","volume":"116","author":"Palladini","year":"2010","unstructured":"11. Palladini G, Barassi A, Klersy C, Pacciolla R, Milani P, Sarais G, et al. The Combination of High-sensitivity Cardiac Troponin T (hs-cTnT) at Presentation and Changes in N-Terminal Natriuretic Peptide Type B (NT-proBNP) After Chemotherapy Best Predicts Survival in AL Amyloidosis. Blood. 2010;116(18):3426-30. doi: 10.1182\/blood-2010-05-286567.","journal-title":"Blood"},{"issue":"2","key":"key20220517104335_B12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13506129.2014.884971","article-title":"Biohumoral Markers as Predictor of Right Ventricular Dysfunction in AL Amyloidosis","volume":"21","author":"Cappelli","year":"2014","unstructured":"12. Cappelli F, Baldasseroni S, Bergesio F, Padeletti L, Attan\u00e0 P, Pignone AM, et al. Biohumoral Markers as Predictor of Right Ventricular Dysfunction in AL Amyloidosis. Amyloid. 2014;21(2):97-102. doi: 10.3109\/13506129.2014.884971.","journal-title":"Amyloid"},{"issue":"8","key":"key20220517104335_B13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","unstructured":"13. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Ann Intern Med. 2011;155(8):529-36. doi: 10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"issue":"11","key":"key20220517104335_B14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The Diagnostic Odds Ratio: A Single Indicator of test Performance","volume":"56","author":"Glas","year":"2003","unstructured":"14. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The Diagnostic Odds Ratio: A Single Indicator of test Performance. J Clin Epidemiol. 2003;56(11):1129-35. doi: 10.1016\/s0895-4356(03)00177-x.","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"key20220517104335_B15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining Independent Studies of a Diagnostic Test into a Summary ROC Curve: Data-analytic Approaches and Some Additional Considerations","volume":"12","author":"Moses","year":"1993","unstructured":"15. Moses LE, Shapiro D, Littenberg B. Combining Independent Studies of a Diagnostic Test into a Summary ROC Curve: Data-analytic Approaches and Some Additional Considerations. Stat Med. 1993;12(14):1293-316. doi: 10.1002\/sim.4780121403.","journal-title":"Stat Med"},{"issue":"7414","key":"key20220517104335_B16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring Inconsistency in Meta-analyses","volume":"327","author":"Higgins","year":"2003","unstructured":"16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring Inconsistency in Meta-analyses. BMJ. 2003;327(7414):557-60. doi: 10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"key20220517104335_B17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-2-9","article-title":"Conducting Systematic Reviews of Diagnostic Studies: Didactic Guidelines","volume":"2","author":"Devill\u00e9","year":"2002","unstructured":"17. Devill\u00e9 WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting Systematic Reviews of Diagnostic Studies: Didactic Guidelines. BMC Med Res Methodol. 2002;2:9. doi: 10.1186\/1471-2288-2-9.","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"key20220517104335_B18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The Performance of Tests of Publication Bias and Other Sample Size Effects in Systematic Reviews of Diagnostic Test Accuracy was Assessed","volume":"58","author":"Deeks","year":"2005","unstructured":"18. Deeks JJ, Macaskill P, Irwig L. The Performance of Tests of Publication Bias and Other Sample Size Effects in Systematic Reviews of Diagnostic Test Accuracy was Assessed. J Clin Epidemiol. 2005;58(9):882-93. doi: 10.1016\/j.jclinepi.2005.01.016.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"key20220517104335_B19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM197507312930513","article-title":"Nomogram for Bayes theorem","volume":"293","author":"Letter","year":"1975","unstructured":"19. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med. 1975;293(5):257. doi: 10.1056\/NEJM197507312930513.","journal-title":"N Engl J Med"},{"key":"key20220517104335_B20","volume-title":"MIDAS: Stata Module for Meta-Analytical Integration of Diagnostic Test Accuracy Studies","author":"Dwamena","year":"2007","unstructured":"20. Dwamena B. MIDAS: Stata Module for Meta-Analytical Integration of Diagnostic Test Accuracy Studies. Boston: Boston College; 2007."},{"issue":"4","key":"key20220517104335_B21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/13506129.2013.825240","article-title":"Role of Natriuretic Peptide to Predict Cardiac Abnormalities in Patients with Hereditary Transthyretin Amyloidosis","volume":"20","author":"Damy","year":"2013","unstructured":"21. Damy T, Deux JF, Moutereau S, Guendouz S, Mohty D, Rappeneau S, et al. Role of Natriuretic Peptide to Predict Cardiac Abnormalities in Patients with Hereditary Transthyretin Amyloidosis. Amyloid. 2013;20(4):212-20. doi: 10.3109\/13506129.2013.825240.","journal-title":"Amyloid"},{"issue":"1","key":"key20220517104335_B22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2017.09.029","article-title":"Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide","volume":"121","author":"Klaassen","year":"2018","unstructured":"22. Klaassen SHC, Tromp J, Nienhuis HLA, van der Meer P, van den Berg MP, Blokzijl H, et al. Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide. Am J Cardiol. 2018;121(1):107-12. doi: 10.1016\/j.amjcard.2017.09.029.","journal-title":"Am J Cardiol"},{"issue":"4","key":"key20220517104335_B23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13506120903421538","article-title":"Serum Levels of NT-proBNP as Surrogate for Cardiac Amyloid Burden: New Evidence from Gadolinium-enhanced Cardiac Magnetic Resonance Imaging in Patients with Amyloidosis","volume":"16","author":"Lehrke","year":"2009","unstructured":"23. Lehrke S, Steen H, Kristen AV, Merten C, Lossnitzer D, Dengler TJ, et al. Serum Levels of NT-proBNP as Surrogate for Cardiac Amyloid Burden: New Evidence from Gadolinium-enhanced Cardiac Magnetic Resonance Imaging in Patients with Amyloidosis. Amyloid. 2009;16(4):187-95. doi: 10.3109\/13506120903421538.","journal-title":"Amyloid"},{"issue":"19","key":"key20220517104335_B24","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-Terminal Pro-brain Natriuretic Peptide is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis","volume":"107","author":"Palladini","year":"2003","unstructured":"24. Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, et al. Serum N-Terminal Pro-brain Natriuretic Peptide is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis. Circulation. 2003;107(19):2440-5. doi: 10.1161\/01.CIR.0000068314.02595.B2.","journal-title":"Circulation"},{"issue":"5","key":"key20220517104335_B25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ehjci\/jez180","article-title":"Diagnostic Score of Cardiac Involvement in AL Amyloidosis","volume":"21","author":"Nicol","year":"2020","unstructured":"25. Nicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, et al. Diagnostic Score of Cardiac Involvement in AL Amyloidosis. Eur Heart J Cardiovasc Imaging. 2020;21(5):542-8. doi: 10.1093\/ehjci\/jez180.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"key20220517104335_B26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ajh.23141","article-title":"Best Use of Cardiac Biomarkers in Patients with AL Amyloidosis and Renal Failure","volume":"87","author":"Palladini","year":"2012","unstructured":"26. Palladini G, Foli A, Milani P, Russo P, Albertini R, Lavatelli F, et al. Best Use of Cardiac Biomarkers in Patients with AL Amyloidosis and Renal Failure. Am J Hematol. 2012;87(5):465-71. doi: 10.1002\/ajh.23141.","journal-title":"Am J Hematol"},{"issue":"10","key":"key20220517104335_B27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac Amyloidosis: Updates in Diagnosis and Management","volume":"106","author":"Mohty","year":"2013","unstructured":"27. Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al. Cardiac Amyloidosis: Updates in Diagnosis and Management. Arch Cardiovasc Dis. 2013;106(10):528-40. doi: 10.1016\/j.acvd.2013.06.051.","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"key20220517104335_B28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 Mapping and Survival in Systemic Light-Chain Amyloidosis","volume":"36","author":"Banypersad","year":"2015","unstructured":"28. Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, et al. T1 Mapping and Survival in Systemic Light-Chain Amyloidosis. Eur Heart J. 2015;36(4):244-51. doi: 10.1093\/eurheartj\/ehu444.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20220517104335_B29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00392-014-0779-y","article-title":"Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor","volume":"104","author":"Kristen","year":"2015","unstructured":"29. Kristen AV, Rinn J, Hegenbart U, Lindenmaier D, Merkle C, R\u00f6cken C, et al. Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. Clin Res Cardiol. 2015;104(3):250-7. doi: 10.1007\/s00392-014-0779-y.","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"key20220517104335_B30","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic Light Chains Induce Cardiomyocyte Contractile Dysfunction and Apoptosis via a Non-canonical p38alpha MAPK Pathway","volume":"107","author":"Shi","year":"2010","unstructured":"30. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, et al. Amyloidogenic Light Chains Induce Cardiomyocyte Contractile Dysfunction and Apoptosis via a Non-canonical p38alpha MAPK Pathway. Proc Natl Acad Sci U S A. 2010;107(9):4188-93. doi: 10.1073\/pnas.0912263107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"key20220517104335_B31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2011.02.015","article-title":"Distinct Regulation of B-type Natriuretic Peptide Transcription by p38 MAPK Isoforms","volume":"338","author":"Koivisto","year":"2011","unstructured":"31. Koivisto E, Kaikkonen L, Tokola H, Pikkarainen S, Aro J, Pennanen H, et al. Distinct Regulation of B-type Natriuretic Peptide Transcription by p38 MAPK Isoforms. Mol Cell Endocrinol. 2011;338(1-2):18-27. doi: 10.1016\/j.mce.2011.02.015.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"key20220517104335_B32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MCP.0b013e3283455cda","article-title":"Utilization of B-Type Natriuretic Peptide and NT-proBNP in the Diagnosis of Pleural Effusions Due to Heart Failure","volume":"17","author":"Porcel","year":"2011","unstructured":"32. Porcel JM. Utilization of B-Type Natriuretic Peptide and NT-proBNP in the Diagnosis of Pleural Effusions Due to Heart Failure. Curr Opin Pulm Med. 2011;17(4):215-9. doi: 10.1097\/MCP.0b013e3283455cda.","journal-title":"Curr Opin Pulm Med"},{"key":"key20220517104335_B33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2017.02.064","article-title":"Prognostic Power of NT-proBNP in Left Ventricular Non-compaction Cardiomyopathy","volume":"236","author":"St\u00e4mpfli","year":"2017","unstructured":"33. St\u00e4mpfli SF, Erhart L, Hagenbuch N, St\u00e4hli BE, Gruner C, Greutmann M, et al. Prognostic Power of NT-proBNP in Left Ventricular Non-compaction Cardiomyopathy. Int J Cardiol. 2017;236:321-7. doi: 10.1016\/j.ijcard.2017.02.064.","journal-title":"Int J Cardiol"},{"issue":"2","key":"key20220517104335_B34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1213\/ANE.0000000000001736","article-title":"Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP","volume":"124","author":"Kopec","year":"2017","unstructured":"34. Kopec M, Duma A, Helwani MA, Brown J, Brown F, Gage BF, et al. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP. Anesth Analg. 2017;124(2):398-405. doi: 10.1213\/ANE.0000000000001736.","journal-title":"Anesth Analg"},{"issue":"3","key":"key20220517104335_B35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP Testing for Diagnosis and Short-term Prognosis in Acute Destabilized Heart Failure: An International Pooled Analysis of 1256 Patients: The International Collaborative of NT-proBNP Study","volume":"27","author":"Januzzi","year":"2006","unstructured":"35. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP Testing for Diagnosis and Short-term Prognosis in Acute Destabilized Heart Failure: An International Pooled Analysis of 1256 Patients: The International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27(3):330-7. doi: 10.1093\/eurheartj\/ehi631.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20220517104335_B36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejheart.2004.01.010","article-title":"NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies","volume":"6","author":"McDonagh","year":"2004","unstructured":"36. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies. Eur J Heart Fail. 2004;6(3):269-73. doi: 10.1016\/j.ejheart.2004.01.010.","journal-title":"Eur J Heart Fail"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/papel-diagnostico-do-nt-probnp-em-pacientes-com-comprometimento-por-amiloidose-cardiaca-uma-metanalise\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:09:16Z","timestamp":1747400956000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/papel-diagnostico-do-nt-probnp-em-pacientes-com-comprometimento-por-amiloidose-cardiaca-uma-metanalise\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":36,"alternative-id":["10.36660\/abc.20210486"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210486","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]}}}